Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Storkus

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Stem Cells (Dayton, Ohio)|January 1, 1997
Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccinesJ I Mayordomo, T Zorina, W J Storkus, et al.
Gene Therapy|April 26, 2001
Direct transfection and activation of human cutaneous dendritic cellsA T Larregina, S C Watkins, G Erdos, et al.
Human Immunology|February 1, 1994
Flow-cytometric determination of peptide-class I complex formation. Identification of p53 peptides that bind to HLA-A2H J Zeh, G H Leder, M T Lotze, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 3, 2007
EBV-specific CD8+ T cell reactivation in transplant patients results in expansion of CD8+ type-1 regulatory T cellsI Popescu, C Macedo, K Abu-Elmagd, et al.
Human Gene Therapy|December 1, 1994
Construction and characterization of retroviral vectors expressing biologically active human interleukin-12L Zitvogel, H Tahara, Q Cai, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2000
Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cellsH M Zarour, J M Kirkwood, L S Kierstead, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1995
Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vectorH Tahara, L Zitvogel, W J Storkus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1996
Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6M J Maeurer, S M Gollin, W J Storkus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1996
Multiple melanoma-associated epitopes recognized by HLA-A3-restricted CTLs and shared by melanomas but not melanocytesA Mazzocchi, W J Storkus, C Traversari, et al.
Journal of Virology|November 13, 1999
Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccinationE Ranieri, W Herr, A Gambotto, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Stem Cells (Dayton, Ohio)|January 1, 1997
Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccinesJ I Mayordomo, T Zorina, W J Storkus, et al.
Gene Therapy|April 26, 2001
Direct transfection and activation of human cutaneous dendritic cellsA T Larregina, S C Watkins, G Erdos, et al.
Human Immunology|February 1, 1994
Flow-cytometric determination of peptide-class I complex formation. Identification of p53 peptides that bind to HLA-A2H J Zeh, G H Leder, M T Lotze, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 3, 2007
EBV-specific CD8+ T cell reactivation in transplant patients results in expansion of CD8+ type-1 regulatory T cellsI Popescu, C Macedo, K Abu-Elmagd, et al.
Human Gene Therapy|December 1, 1994
Construction and characterization of retroviral vectors expressing biologically active human interleukin-12L Zitvogel, H Tahara, Q Cai, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2000
Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cellsH M Zarour, J M Kirkwood, L S Kierstead, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1995
Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vectorH Tahara, L Zitvogel, W J Storkus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1996
Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6M J Maeurer, S M Gollin, W J Storkus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1996
Multiple melanoma-associated epitopes recognized by HLA-A3-restricted CTLs and shared by melanomas but not melanocytesA Mazzocchi, W J Storkus, C Traversari, et al.
Journal of Virology|November 13, 1999
Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccinationE Ranieri, W Herr, A Gambotto, et al.
Pageof 8